Purple Biotech Ltd - American Depositary Shares — Cash Flow (NASDAQ:PPBT) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -12.09 M-374 K16.73 M19.93 M-14.37 M-5.66 M — Cash from investing activities -49.59 M13.41 M19.91 M13.88 M509 K632 K — Cash from financing activities 68.49 M01.11 M5.45 M6.77 M6.33 M — Free cash flow -12.09 M-374 K16.73 M19.93 M-14.37 M-5.66 M —

News

H.C. Wainwright cuts Purple Biotech stock price target to $30

Purple Biotech CEO Gil Efron to step down in August 2026

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.15%

Upcoming Stock Splits This Week (March 2 to March 6) – Stay Invested - TipRanks.com

Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - CERo Therapeutics Hldgs (NASDAQ:CERO), Aditxt (NASDAQ:ADTX)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.15%

Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories! - TipRanks.com

Purple Biotech stock soars after manufacturing milestone for tri-specific antibody

Dow Surges 250 Points; Verizon Posts Mixed Q3 Results - Cambium Networks (NASDAQ:CMBM), Advent Technologies Hldgs (NASDAQ:ADN)

Purple Biotech Announces Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Platform

H.C. Wainwright lifts Purple Biotech stock target to $34

Purple Biotech Reports First Quarter 2025 Financial Results